Chronic rhinitis solution NEUROMARK secures €62.5 million as Irish startup Neurent Medical closes Series C
Chronic rhinitis solution NEUROMARK secures €62.5 million as Irish startup Neurent Medical closes Series C Galway-based Neurent Medical, the company behind NEUROMARK, a minimally invasive solution to treat chronic rhinitis, today announced the successful close of its oversubscribed Series C financing, raising €62.5 million ($74 million) to drive commercial expansion,

